MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12020-021-02900-0

Медицинская библиотека · Endocrine · 2021

Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study.

Marazuela Mónica, Blanco Concepción, Bernabeu Ignacio, Menendez Edelmiro, Villar Rocío, Paja Miguel, Sampedro-Nuñez Miguel, Samaniego M Luz, Díaz-Muñoz Marcos, Sánchez-Cenizo Laura

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

To evaluate disease activity status using the Acromegaly Disease Activity Tool (ACRODAT®) in a cohort of Spanish acromegaly patients, to assess the relationship between the level of disease activity according to both ACRODAT® and the physicians' clinical evaluation, and to study the potential discrepancies in the perception of symptoms between physicians and patients.

DESIGN

Multicenter, observational, descriptive and cross-sectional study.

METHODS

Disease activity was assessed in adult patients with acromegaly under pharmacological treatment during at least 6 months using ACRODAT®.

RESULTS

According to ACRODAT®, 48.2%, 31.8% and 20.0% of a total of 111 patients were classified as having a stable disease (S), mild disease activity (M-DA) and significant disease activity (S-DA) respectively. ACRODAT® classification of disease activity significantly correlated with physicians' opinion, with a moderate inter-rater agreement and a specificity of 92.45% (PPV = 86.21%). No correlation was found between IGF-I levels and severity of symptoms or quality of life (QoL). A decision to take clinical action was significantly more frequent in S-DA and M-DA patients than S patients but no action was taken on 5 (22.7%) and 27 (77.1%) S-DA and M-DA patients, respectively

CONCLUSIONS

ACRODAT® detected disease activity in 51.8% of patients. Interestingly, although M-DA and S-DA patients were likely to be in the process of being controlled, action was not always taken on these patients. ACRODAT® is a validated and highly specific tool that may be useful to routinely monitor acromegaly and to identify patients with non-obvious disease activity by incorporating "patient-centred" parameters like symptoms and QoL to the clinical evaluation of acromegaly.

Для цитирования: Marazuela Mónica, Blanco Concepción, Bernabeu Ignacio, Menendez Edelmiro, Villar Rocío, Paja Miguel, Sampedro-Nuñez Miguel, Samaniego M Luz, Díaz-Muñoz Marcos, Sánchez-Cenizo Laura. Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study.. Endocrine. 2021. DOI: 10.1007/s12020-021-02900-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.